Literature DB >> 19557628

Therapy-related acute promyelocytic leukemia: further insights into the molecular basis of the disease and showing the way forward in therapy.

Farhad Ravandi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19557628      PMCID: PMC4109290          DOI: 10.1080/10428190902995655

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  13 in total

1.  Therapy-related MDS and AML in acute promyelocytic leukemia.

Authors:  Mette Klarskov Andersen; Jens Pedersen-Bjergaard
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

2.  Anti-leukemic and anti-angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia.

Authors:  Kamran Alimoghaddam; Ahmad Shariftabrizi; S Mohammad Tavangar; Mohammad Tavangar; Zohreh Sanaat; Shahrbanoo Rostami; Mohammad Jahani; Ardeshir Ghavamzadeh
Journal:  Leuk Lymphoma       Date:  2006-01

3.  Use of arsenic trioxide in secondary acute promyelocytic leukemia developing after treatment of multiple sclerosis with mitoxantrone.

Authors:  Emanuele Ammatuna; Enrico Montefusco; Matteo Pacilli; Mariadomenica Divona; Davide Ardiri; Diego Centonze; Francesco Lo-Coco
Journal:  Leuk Lymphoma       Date:  2009-07

4.  Acute promyelocytic leukemia after Stanford V plus radiotherapy for advanced Hodgkin lymphoma.

Authors:  Savina Maria Luciana Aversa; Chiara Trentin; Mariella Sorarů; Eros Di Bona; Dario Marino; Fabio Canova; Luigi Salvagno; Fausto Adami
Journal:  Leuk Lymphoma       Date:  2009-07

5.  United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.

Authors:  S L Soignet; S R Frankel; D Douer; M S Tallman; H Kantarjian; E Calleja; R M Stone; M Kalaycio; D A Scheinberg; P Steinherz; E L Sievers; S Coutré; S Dahlberg; R Ellison; R P Warrell
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

6.  DNA topoisomerase II in therapy-related acute promyelocytic leukemia.

Authors:  Anita R Mistry; Carolyn A Felix; Ryan J Whitmarsh; Annabel Mason; Andreas Reiter; Bruno Cassinat; Anne Parry; Christoph Walz; Joseph L Wiemels; Mark R Segal; Lionel Adès; Ian A Blair; Neil Osheroff; Andrew J Peniket; Marina Lafage-Pochitaloff; Nicholas C P Cross; Christine Chomienne; Ellen Solomon; Pierre Fenaux; David Grimwade
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

Review 7.  The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation.

Authors:  J Pedersen-Bjergaard; J D Rowley
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

8.  Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.

Authors:  Alessandro Pulsoni; Livio Pagano; Francesco Lo Coco; Giuseppe Avvisati; Luca Mele; Eros Di Bona; Rosangela Invernizzi; Franco Leoni; Filippo Marmont; Alfonso Mele; Lorella Melillo; Anna Maria Nosari; Enrico Maria Pogliani; Marco Vignetti; Giuseppe Visani; Vittorina Zagonel; Giuseppe Leone; Franco Mandelli
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

9.  Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).

Authors:  G Garcia-Manero; H M Kantarjian; S Kornblau; E Estey
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

10.  Therapy-related acute promyelocytic leukemia.

Authors:  M Beaumont; M Sanz; P M Carli; F Maloisel; X Thomas; L Detourmignies; A Guerci; N Gratecos; C Rayon; J San Miguel; J Odriozola; J Y Cahn; F Huguet; A Vekhof; A Stamatoulas; H Dombret; F Capote; J Esteve; A M Stoppa; P Fenaux
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

View more
  4 in total

1.  [Mitoxantrone-related acute leukemia by multiple sclerosis. Case report and practical approach by unclear cytopenia].

Authors:  C Meyer; N Ansorge; I Siglienti; S Salmen; A Stroet; H Nückel; U Dührsen; P R Ritter; W E Schmidt; R Gold; A Chan
Journal:  Nervenarzt       Date:  2010-12       Impact factor: 1.214

2.  CRABP-II methylation: a critical determinant of retinoic acid resistance of medulloblastoma cells.

Authors:  Yuan-Shan Fu; Qian Wang; Jing-Xin Ma; Xiang-Hong Yang; Mo-Li Wu; Kai-Li Zhang; Qing-You Kong; Xiao-Yan Chen; Yuan Sun; Nan-Nan Chen; Xiao-Hong Shu; Hong Li; Jia Liu
Journal:  Mol Oncol       Date:  2011-11-25       Impact factor: 6.603

3.  Treatment of acute promyelocytic leukemia for older patients.

Authors:  Thomas Prebet; Steven D Gore
Journal:  J Natl Compr Canc Netw       Date:  2011-03       Impact factor: 11.908

4.  Therapy-related acute promyelocytic leukemia in plasma cell myeloma treated with melphalan: a case report and literature review.

Authors:  Hyunjung Gu; Young Jin Kim; Woo-In Lee; Juhee Lee; Hwi-Joong Yoon; Tae Sung Park
Journal:  Blood Res       Date:  2017-03-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.